Quinoline/Pyrido‐Pyrimidine Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis, Computational, and Anticancer Evaluation
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Divyakshi Arya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, D.D.U. Gorakhpur University, Gorakhpur, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Tubulin Modulators, Drug Design, Tubulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Cancer prevails a substantial health threat, with breast and colon cancers being the second and third most recurrent worldwide. In recent decades, quinoline/pyrido[2,3‐d]pyrimidin‐4(3H)‐one derivatives have procured attention as propitious anticancer agents. This study acquaint a series of such compounds synthesized and characterized using spectroscopic (1H NMR, 13C NMR, IR, MS) and computational (DFT) methods. Their tubulin polymerization inhibitory and antiproliferative activities were assessed against cancer cell lines MCF‐7, MDA‐MB‐231, and HCT‐116, accompanying cytotoxicity screening against normal HEK‐293 cells, divulging selective anticancer potential. SAR study accentuated the role of methoxy‐substituted phenyl and cycloheptane rings in escalating activity. Peculiarly, compound 4g (IC 50 = 3.02 ± 0.63 μM against cell line MCF‐7) exhibited profound tubulin inhibition and was additionally substantiated via molecular docking and dynamics simulations, ratifying its drug‐like behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, D.D.U. Gorakhpur University, Gorakhpur, Uttar Pradesh, India.
- College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, China.
- Central Department of Physics, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
- Central Department of Chemistry, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
- Department of Chemistry, D.A.V. P.G. College, Gorakhpur, Uttar Pradesh, India.
- GITAM School of Pharmacy, GITAM (Deemed to be) University, Hyderabad, India.
ORCID-Profile: Shweta Singh, Bharat Prasad Sharma, Rajesh Maharjan, Ashish Ranjan Dwivedi, Sarvesh Kumar Pandey
Zitieren
APA
Arya, D., Khan, G. A., Singh, S., Upadhyay, A., Sharma, B. P., Maharjan, R., Sharma, M. L., Gupt, M. P., Dubey, S. S., Pathak, P., Dwivedi, A. R., & Pandey, S. K. (2025). Quinoline/Pyrido‐Pyrimidine Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis, Computational, and Anticancer Evaluation. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70172
Vancouver
Arya D, Khan GA, Singh S, Upadhyay A, Sharma BP, Maharjan R, et al. Quinoline/Pyrido‐Pyrimidine Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis, Computational, and Anticancer Evaluation. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70172
BibTeX
@article{Arya2025,
author = {Arya, Divyakshi and Khan, Gulshan Aara and Singh, Shweta and Upadhyay, Anjali and Sharma, Bharat Prasad and Maharjan, Rajesh and Sharma, Motee Lal and Gupt, Munna P and Dubey, Som Shankar and Pathak, Prateek and Dwivedi, Ashish Ranjan and Pandey, Sarvesh Kumar},
title = {Quinoline/Pyrido‐Pyrimidine Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis, Computational, and Anticancer Evaluation},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70172}
}
EUVIMED